scholarly journals Basal Forebrain Deep Brain Stimulation Impacts the Regulation of Extracellular Vesicle Related Proteins in the Rat Brain

2018 ◽  
Author(s):  
Wenxue Li ◽  
Laura Lozano Montes ◽  
Jayakrishnan Nair ◽  
Marta Dimanico ◽  
Reza Mazloum ◽  
...  

AbstractExtracellular vesicle (EV) signaling has attracted considerable attention in recent years because EVs play a key role in long distance cellular communication functions. EV studies have begun to reveal aspects of physiological and physiopathological regulation in numerous applications, although many areas remain to date largely unexplored. Deep brain stimulation (DBS) has shown remarkable therapeutic benefits of patients with neuropsychiatric disorders, but despite of the long and successful history of use, the mechanisms of action on neural ensemble activity are not yet fully understood. Here we explore how DBS of the basal forebrain impacts EV signaling in the rat brain. We employed differential centrifugations to isolate the EVs prefrontal cortex (PFC), hippocampus and striatum. We then performed quantitative analysis of EV-associated proteins using an MS-based proteomics method. We identified a considerable number of EV-associated proteins are modulated by DBS in three brain regions, some of which have been previously linked with central nervous system disorders. Particularly, neurofilament proteins NFL and NFM were both significantly changed in EVs of PFC, hippocampus and striatum after DBS stimulation compared with controls. The SOD1 protein, associated previously with neurodegenerative diseases, was significantly increased only in PFC. Our study is the first, to our knowledge, to use EV protein analysis to examine DBS effects on brain physiological regulation. Our findings open an entirely new perspective on brain area specific DBS effects.

2014 ◽  
Vol 45 (01) ◽  
Author(s):  
N Van Den Berge ◽  
V Keereman ◽  
C Vanhove ◽  
P van Mierlo ◽  
B Van Nieuwenhuyse ◽  
...  

2015 ◽  
Vol 8 (2) ◽  
pp. 351-352
Author(s):  
N. Van Den Berge ◽  
I. Dauwe ◽  
C. vanhove ◽  
B. Descamps ◽  
P. Van Mierlo ◽  
...  

2014 ◽  
Vol 17 (3) ◽  
pp. 373-383 ◽  
Author(s):  
Nathalie Van Den Berge ◽  
Vincent Keereman ◽  
Christian Vanhove ◽  
Bregt Van Nieuwenhuyse ◽  
Pieter van Mierlo ◽  
...  

PLoS ONE ◽  
2015 ◽  
Vol 10 (7) ◽  
pp. e0133245 ◽  
Author(s):  
Nathalie Van Den Berge ◽  
Christian Vanhove ◽  
Benedicte Descamps ◽  
Ine Dauwe ◽  
Pieter van Mierlo ◽  
...  

2018 ◽  
Vol 28 (7) ◽  
pp. 813-818
Author(s):  
Sheng-Tzung Tsai ◽  
Horng-Jyh Harn ◽  
Shinn-Zong Lin ◽  
Guo-Fang Tseng ◽  
Shin-Yuan Chen

Acute (e.g., traumatic brain injury or stroke) and chronic (e.g., dementia or Parkinson’s disease dementia) neurological disorders that involve cognitive impairment and dysfunctional neural circuits always lead to a dreadful and costly experience for patients and their families. The application of deep brain stimulation for the treatment of neuropsychiatric disorders has shown great potential to modulate pathological neural circuits and trigger endogenous neurogenesis. We summarize several important clinical and translational studies that utilize deep brain stimulation to improve cognition based on the potentiation of neural plasticity and neurogenesis. In addition, we discuss the neuroanatomy and cerebral circuits implicated in such studies as well as the potential mechanisms underlying therapeutic benefits.


2020 ◽  
Vol 14 ◽  
Author(s):  
Yvan M. Vachez ◽  
Meaghan C. Creed

Deep brain stimulation of the subthalamic nucleus (STN-DBS) is an effective treatment for the motor symptoms of movement disorders including Parkinson's Disease (PD). Despite its therapeutic benefits, STN-DBS has been associated with adverse effects on mood and cognition. Specifically, apathy, which is defined as a loss of motivation, has been reported to emerge or to worsen following STN-DBS. However, it is often challenging to disentangle the effects of STN-DBS per se from concurrent reduction of dopamine replacement therapy, from underlying PD pathology or from disease progression. To this end, pre-clinical models allow for the dissociation of each of these factors, and to establish neural substrates underlying the emergence of motivational symptoms following STN-DBS. Here, we performed a systematic analysis of rodent studies assessing the effects of STN-DBS on reward seeking, reward motivation and reward consumption across a variety of behavioral paradigms. We find that STN-DBS decreases reward seeking in the majority of experiments, and we outline how design of the behavioral task and DBS parameters can influence experimental outcomes. While an early hypothesis posited that DBS acts as a “functional lesion,” an analysis of lesions and inhibition of the STN revealed no consistent pattern on reward-related behavior. Thus, we discuss alternative mechanisms that could contribute to the amotivational effects of STN-DBS. We also argue that optogenetic-assisted circuit dissection could yield important insight into the effects of the STN on motivated behavior in health and disease. Understanding the mechanisms underlying the effects of STN-DBS on motivated behavior-will be critical for optimizing the clinical application of STN-DBS.


Sign in / Sign up

Export Citation Format

Share Document